Publisher: Cambridge University Press
E-ISSN: 1469-2147|26|3|398-410
ISSN: 0963-1801
Source: Cambridge Quarterly of Healthcare Ethics, Vol.26, Iss.3, 2017-05, pp. : 398-410
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Outcomes in CKD: What We Know and What We Need to Know
Nephron Clin Pract, Vol. 114, Iss. 2, 2009-11 ,pp. :
Moral Bioenhancement and Free Will: Continuing the Debate
Cambridge Quarterly of Healthcare Ethics, Vol. 26, Iss. 3, 2017-05 ,pp. :
Commentary: Moral Bioenhancement Worthy of the Name
Cambridge Quarterly of Healthcare Ethics, Vol. 26, Iss. 3, 2017-05 ,pp. :
Incidental Pancreatic Cysts: Do We Really Know What We Are Watching?
Pancreatology, Vol. 10, Iss. 2-3, 2010-05 ,pp. :
Cannabinoids for epilepsy: What do we know and where do we go?
EPILEPSIA, Vol. 59, Iss. 2, 2018-02 ,pp. :